These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30503137)

  • 1. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
    Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
    Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.
    Kazemi Jaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Hosseinpanah F; Khalili D; Cheraghi L; Azizi F
    Fertil Steril; 2017 Dec; 108(6):1078-1084. PubMed ID: 29202960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
    Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
    Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study.
    Behboudi-Gandevani S; Amiri M; Cheraghi L; Amanollahi Soudmand S; Azizi F; Ramezani Tehrani F
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):590-597. PubMed ID: 32654166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome.
    Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S
    Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Subramanian A; Anand A; Adderley NJ; Okoth K; Toulis KA; Gokhale K; Sainsbury C; O'Reilly MW; Arlt W; Nirantharakumar K
    Eur J Endocrinol; 2021 May; 184(5):637-645. PubMed ID: 33635829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors.
    Shi Y; Cui Y; Sun X; Ma G; Ma Z; Gao Q; Chen ZJ
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():66-70. PubMed ID: 24368020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Zhu S; Zhang B; Jiang X; Li Z; Zhao S; Cui L; Chen ZJ
    Fertil Steril; 2019 Jan; 111(1):168-177. PubMed ID: 30611404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS).
    Macut D; Micić D; Cvijović G; Sumarac M; Kendereski A; Zorić S; Pejković D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1353-59; discussion 1365. PubMed ID: 11964034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E; Campagna AM; Lobo RA
    Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
    Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.